Slide 1: Full Year Presentation August 2023
For personal use only Full Year Presentation August 2023 Constant care, everywhere
Slide 2: Disclaimer and Important Notices
Disclaimer and Important Notices This presentation has been prepared by Careteq Limited ACN 612 267 857 This presentation may contain forward-looking statements, guidance, assumptions, uncertainties and contingencies which may affect future (Company). It contains general background information only
Slide 3: FY2023 Result Highlights
FY2023 Result Highlights Cost Reductions FY23 was an important year in laying a solid foundation to drive further revenue Annualised saving in excess of growth and build towards profitability. The Company saw rapid expansion in its $1.2m for FY24 to be achieved For personal use only Australian and U
Slide 4: FY2023 Result Highlights - Group
FY2023 Result Highlights - Group Foundation set for FY24 and beyond For personal use only Group Operating Revenue ($m) Revenue Up 23.1% over pcp to $6.4m 7 6 5 EBITDA 4 $0.6m improvement to ($3.5m) 3 2 Outlook 1 Organic growth expected across the group on an optimised cost base. 0 FY20 FY21 FY22 FY2
Slide 5: FY2023 Result Highlights - Sofihub
FY2023 Result Highlights - Sofihub Gathering momentum with sticky customers and a robust pipeline For personal use only FY23 FY22 Change Sofihub SaaS subscribers Revenue2 $0.9m $0.9m - 6,000 5,000 EBITDA2 ($4.3m)3 ($4.4m)3 2.3% Sofihub subscribers 4,000 ARR1 $309k $220k 40.45% 3,000 2,000 Subscriber
Slide 6: FY2023 Result Highlights - EHS
FY2023 Result Highlights - EHS Strategic JV to significantly boost profitability and productivity For personal use only FY23 FY22 % Change Merger Medication Revenue $5.5m1 $4.3m 27.9% Ward MM merged with Management Mederev in a JV called This created one of Embedded Health Australia’s largest aged E
Slide 7: Capital structure / Company Overview
Capital structure Company Overview Delivering innovative health and aged care solutions For personal use only Share price (28th August 2023) $0.026 Shares on issue 222.1m Market capitalisation $5.7m Cash (proforma post capital raise of $2.47m) $4.0m SaaS Based Devices Assistive Living R&D loan ($m)
Slide 8: Leveraged to Large Global Markets
Leveraged to Large Global Markets Aged & disability care industry ripe for tech disruption For personal use only CARETEQ closing in on cashflow breakeven inflection point ...driven by multiple tailwinds (15K subscriber target) Ageing Population Funding More room for growth... Rapidly Ageing populati
Slide 9: Business Model
Software: Services: SaaS Platforms Embedded Health Solutions 3 SOLUTION Business For personal use only Assistive Electronic Medication Living Medication Management Model Technology Management Services Commercially ready Cloud-based platform, SaaS-based system, Medication management services DESCRIPT
Slide 10: Assistive Living Technology
For personal use only Assistive Living Technology Full Year Presentation | 10
Slide 11: SaaS Platform
SaaS Platform Scalable SaaS platform that provides critical data and AI-powered insights from best of breed hardware For personal use only Real-time Data Constant real-time stream of multiple data variables delivering broad detail on activities and occurrences Easy Access Can be accessed through var
Slide 12: CARETEQ's Sales Cycle Explained
Global SAM: $32B1 CARETEQ’s Sales Cycle Explained Channel partner go-to-market strategy For personal use only Active Partners Won ONGOING CARETEQ leverages Active Partners’ client networks. Most Active Partners have large pool of existing clients across SALES Aged Care Facilities multiple verticals
Slide 13: Sofihub Trials and Subscriptions
Sofihub Trials Subscriptions FY24 goal: 15,000+ subs There are currently Converting just one of For personal use only 18 trials running – the trials may lead to a 11 in the U.S. and 7 significant step change and cash flow breakeven in Australia in subscriber numbers run rate1 Growing subscriber base
Slide 14: U.S. Customer Example
U.S. Customer For personal use only Example CARETEQ has several similar sized opportunities in its US pipeline CARETEQ secured an Active Partner who is a leading The partner introduced CARETEQ to a large independent and An initial trial of TEQ-Secure was successfully completed If a contract is succe
Slide 15: Embedded Health Solutions
For personal use only Embedded Health Solutions Medication Management Services Full Year Presentation | 15
Slide 16: Medication Management Services
For personal use only Medication + Management Estimated EBITDA : $1.5m for FY241 Unlocking profit and growth Medication Management Services CARETEQ merged its Ward MM business with Mederev in a JV (via non-cash Revenue & Earnings Growth Platform transaction)1 called Embedded Health A key contributor
Slide 17: New Revenue Opportunity with Global Pharmas
New Revenue Opportunity with Global Pharmas Monetising high-value, high-margin data For personal use only Too early to quantify Value of CARETEQ’s datasets the opportunity but the is increasing due to growth of high-value high-margin High Value of Data data lake1 offering could artificial intelligen
Slide 18: Strong Care Electronic Medication Management
For personal use only Strong Care Electronic Medication Management Full Year Presentation | 18
Slide 19: What is Strong Care?
20hrs+ SAVED MONTHLY Nurses can expect to What is save 20+ hours in administrative tasks For personal use only Strong Care? Innovative cloud-based 50% TIME REDUCTION medication management system Medication round for aged care times reduced up to 50% with the help of CARETEQ is the exclusive reseller
Slide 20: Solid Growth Thematic
The federal For personal use only government is providing grants to RACs to make the digital transition by Dec 2024 ~60-70% of There are >200k RACs are still aged care using inefficient beds in Australia and paper-based digital subscriptions are charged by Solid systems per bed Those who don’t will
Slide 21: Additional Opportunities and Outlook
For personal use only Additional Opportunities and Outlook Full Year Presentation | 21
Slide 22: Additional Growth Opportunities
Lone Worker Market For personal use only Initial sales of TEQ-Secure safety pendants via existing channel partner Early customers include Transport Domestic Accident Commission (TAC) and Hospital-in- Violence Department of Health the-Home Global lone worker safety market US non-profit combating Hosp
Slide 23: Positive Outlook
Positive Outlook Rapidly approaching earnings inflection point For personal use only Approaching 1k contracted beds with Forecasting to reach an additional ~4k breakeven on Group under proposal since operating level with 15k launch in October subs in FY24 2022 Strong cross-selling opportunities for
Slide 24: Deep Experience in Health Care
Deep Experience in Health Care For personal use only Board Directors Mark Simari Alex Boyd Brett Cheong Stephen Munday Executive Chairman Executive Director / COO Non-Executive Director Non-Executive Director Over two decades of experience in Over 40 years of background Over 40 years business experi
Slide 25: Thank You
For personal use only Thank You MARK SIMARI Executive Chairman mark.simari@careteq.com.au SAMANTHA THOMPSON Investor Relations samantha.thompson@careteq.com.au Corporate Address CARETEQ Level 10 99 Queen Street Constant care, everywhere Melbourne, 3000